As the U.S. stock market reaches record highs amid an election-fueled rally, investors are increasingly exploring diverse opportunities to capitalize on this momentum. Penny stocks, often seen as a ...
ATTENTION ESSA Pharma Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights ...
NEW YORK CITY, NY / ACCESSWIRE / November 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ:EPIX). Such investors are ...
Global markets may rally this year on a dovish Fed and cues of U.S.-China trade truce, but India markets failed to join the party. India ETFs have lost in the range of 2% to 9% ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
15h
Leerink Partners analyst David Risinger has reiterated their bullish stance on CNTA stock, giving a Buy rating yesterday. David Risinger has ...
Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Centessa Pharmaceuticals (CNTA – Research Report) today and set a price target of $27.00. The company’s shares closed yesterday at $17.00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback